Document is current
Any future updates will be listed below
-
Authors
Høgdall, Asmus Solyom
Bülow Sand, Jannie Marie
Vognsen, Anna Kubel
Lapperre, Therese
Ulrik, Charlotte Suppli
Leeming, Diana Julie
Karsdal, Morten Asser
Mathioudakis, Alexander G.
Lassen, Mats C. H.
Johansen, Niklas Dyrby
Biering-Sørensen, Tor
Jensen, Jens-Ulrik
Sivapalan, Pradeesh
-
Funding
Funding for this research was provided by:
Herlev-Gentofte University Hospital
- License Information
-
More Information
Article History
Received: 25 September 2025
Accepted: 28 April 2026
First Online: 24 June 2026
Declarations
Competing interests: T.B-S. reports receiving research grants from Sanofi Pasteur and GE Healthcare, is a Steering Committee member of the Amgen financed GALACTIC-HF trial, on advisory boards for Sanofi Pasteur and Amgen, and speaker honorariums from Novartis and Sanofi Pasteur. J.V. reports personal fees from GlaxoSmithKline, Chiesi Pharmaceuticals, Boehringer-Ingelheim, Novartis, and AstraZeneca. JMBS, DJL and MAK are employed at Nordic Bioscience and hold stocks. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. All other authors declare no conflicts of interest.
